SCHEMBL7323958

SCHEMBL7323958

COc1ccccc1C(=O)Nc1ccc(-n2nc(C(F)(F)F)cc2C(F)(F)F)cc1

nearest known ligand 0.87

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
MAPT P10636 7/20 0.87
TP53 P04637 3/20 0.87
THRB P10828 3/20 0.74
SMN1; SMN2 Q16637 3/20 0.74
ORAI1 Q96D31 3/20 0.61
TRPC3 Q13507 3/20 0.61
TRPC1 P48995 1/20 0.61
STIM1 Q13586 1/20 0.61
TRPC5 Q9UL62 1/20 0.57
CRACR2A Q9BSW2 1/20 0.56
POLB P06746 1/20 0.55
NPC1 O15118 1/20 0.53
AHR P35869 1/20 0.53
RAB9A P51151 1/20 0.53
GFER P55789 1/20 0.53
KCNK3 O14649 2/20 0.51
KCNK9 Q9NPC2 2/20 0.51
KDM4E B2RXH2 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7319733 0.90 MAPT (0.71) MAPTTP53THRBSMN1; SMN2ORAI1
SCHEMBL7326399 0.88 MAPT (0.68) MAPTTP53THRBSMN1; SMN2ORAI1
SCHEMBL7323117 0.87 ORAI1 (0.68) MAPTTP53THRBSMN1; SMN2ORAI1
SCHEMBL7328795 0.86 TP53 (0.69) MAPTTP53THRBSMN1; SMN2ORAI1
SCHEMBL7234017 0.86 TP53 (0.86) MAPTTP53THRBSMN1; SMN2ORAI1
SCHEMBL7391879 0.85 MAPT (0.65) MAPTTP53THRBSMN1; SMN2ORAI1
SCHEMBL7324914 0.85 MAPT (0.67) MAPTTP53THRBSMN1; SMN2ORAI1
SCHEMBL7326834 0.85 ORAI1 (0.75) MAPTTP53THRBSMN1; SMN2ORAI1
SCHEMBL7323681 0.85 KDM4E (0.69) MAPTTP53THRBSMN1; SMN2ORAI1
SCHEMBL7323347 0.85 TP53 (0.67) MAPTTP53THRBSMN1; SMN2ORAI1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20010044445-A1 AZOLE INHIBITORS OF CYTOKINE PRODUCTION ABBOTT LABORATORIES 2001-11-22 US claimed
EP-1068187-A1 PYRAZOLE INHIBITORS OF CYTOKINE PRODUCTION ABBOTT LABORATORIES (US) 2001-01-17 EP claimed
WO-1999051580-A1 PYRAZOLE INHIBITORS OF CYTOKINE PRODUCTION ABBOTT LABORATORIES (US) 1999-10-14 WO claimed
US-20010044445-A1 AZOLE INHIBITORS OF CYTOKINE PRODUCTION ABBOTT LABORATORIES 2001-11-22 US disclosed
EP-1068187-A1 PYRAZOLE INHIBITORS OF CYTOKINE PRODUCTION ABBOTT LABORATORIES (US) 2001-01-17 EP disclosed
WO-1999051580-A1 PYRAZOLE INHIBITORS OF CYTOKINE PRODUCTION ABBOTT LABORATORIES (US) 1999-10-14 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20010044445-A1 AZOLE INHIBITORS OF CYTOKINE PRODUCTION IL5, IL2, IL4 MAPT 2674/4885TP53 1903/4885THRB 3730/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.